RecruitingPhase 3NCT07011745
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Sponsor: Bristol-Myers Squibb
Ozark, MO · +41 more sites
Alzheimer's Disease clinical trials in Ozark, MO
1 recruiting alzheimer's disease studies with a site in Ozark, MO.
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.